PIA
TNDM icon

Piedmont Investment Advisors’s Tandem Diabetes Care TNDM Stock Holding History

Piedmont Investment Advisors’s Portfolio TNDM Stock Details TNDM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-775
Closed -$17K – 2161
2018
Q2 		$17K Buy
+775
New +$9.53K ﹤0.01% 1640

Other funds holding TNDM

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
FCM
Frontier Capital Management Boston, Massachusetts $9.73B AUM 55.65% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
TCM
TimesSquare Capital Management New York $5.89B AUM 28.74% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Piedmont Investment Advisors's TNDM Position: Q3 2018 in Review

Piedmont Investment Advisors sold out of Tandem Diabetes Care (TNDM) in Q3 2018, closing a stake of 775 shares — an estimated $17K sold.

Piedmont Investment Advisors first reported a position in TNDM in Q2 2018 and held it in 1 quarter. The position peaked at $17K in Q2 2018. 184 funds tracked by Wall St. Rank hold TNDM as of Q3 2018.

  • Piedmont Investment Advisors reported no remaining Tandem Diabetes Care position as of Q3 2018 after selling out during the quarter.
  • Piedmont Investment Advisors sold 775 Tandem Diabetes Care shares in Q3 2018, an estimated $17K.
  • Piedmont Investment Advisors first reported a position in Tandem Diabetes Care in Q2 2018 and held it in 1 quarter.
  • Piedmont Investment Advisors's Tandem Diabetes Care position peaked at $17K in Q2 2018.
  • 184 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q3 2018.

Based on Piedmont Investment Advisors's 13F filing for Q3 2018, filed 8 Nov 2018.